This NIH center has brought 44 drugs for rare diseases to market — and isn't slowing down

In just the 12 years since its establishment, the National Center for Advancing Translational Sciences has brought 44 FDA-approved drugs for rare diseases to the market — and it shows no signs of slowing down.

Read the full post at Becker's Hospital Review - Healthcare News